nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Tamoxifen—pancreatic cancer	0.0821	0.116	CbGbCtD
Rivaroxaban—CYP3A5—Erlotinib—pancreatic cancer	0.0698	0.0985	CbGbCtD
Rivaroxaban—CYP3A5—Irinotecan—pancreatic cancer	0.063	0.089	CbGbCtD
Rivaroxaban—ABCB1—Tamoxifen—pancreatic cancer	0.0534	0.0754	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—pancreatic cancer	0.0462	0.0652	CbGbCtD
Rivaroxaban—ABCB1—Gemcitabine—pancreatic cancer	0.046	0.065	CbGbCtD
Rivaroxaban—CYP3A5—Sunitinib—pancreatic cancer	0.046	0.0649	CbGbCtD
Rivaroxaban—ABCB1—Erlotinib—pancreatic cancer	0.0454	0.0641	CbGbCtD
Rivaroxaban—ABCB1—Irinotecan—pancreatic cancer	0.041	0.0579	CbGbCtD
Rivaroxaban—CYP3A4—Tamoxifen—pancreatic cancer	0.032	0.0452	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—pancreatic cancer	0.0301	0.0424	CbGbCtD
Rivaroxaban—ABCB1—Sunitinib—pancreatic cancer	0.0299	0.0422	CbGbCtD
Rivaroxaban—CYP3A4—Erlotinib—pancreatic cancer	0.0272	0.0384	CbGbCtD
Rivaroxaban—CYP3A4—Irinotecan—pancreatic cancer	0.0246	0.0347	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—pancreatic cancer	0.0224	0.0316	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—pancreatic cancer	0.018	0.0254	CbGbCtD
Rivaroxaban—CYP3A4—Sunitinib—pancreatic cancer	0.0179	0.0253	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—pancreatic cancer	0.0134	0.019	CbGbCtD
Rivaroxaban—Skin disorder—Gemcitabine—pancreatic cancer	0.000382	0.00131	CcSEcCtD
Rivaroxaban—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00038	0.0013	CcSEcCtD
Rivaroxaban—Dizziness—Tamoxifen—pancreatic cancer	0.000379	0.0013	CcSEcCtD
Rivaroxaban—Tachycardia—Fluorouracil—pancreatic cancer	0.000378	0.0013	CcSEcCtD
Rivaroxaban—Hypotension—Irinotecan—pancreatic cancer	0.000378	0.0013	CcSEcCtD
Rivaroxaban—Dizziness—Erlotinib—pancreatic cancer	0.000375	0.00129	CcSEcCtD
Rivaroxaban—Erythema multiforme—Docetaxel—pancreatic cancer	0.000372	0.00128	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000371	0.00127	CcSEcCtD
Rivaroxaban—Hypotension—Gemcitabine—pancreatic cancer	0.000368	0.00126	CcSEcCtD
Rivaroxaban—Eye disorder—Docetaxel—pancreatic cancer	0.000367	0.00126	CcSEcCtD
Rivaroxaban—Cardiac disorder—Docetaxel—pancreatic cancer	0.000365	0.00125	CcSEcCtD
Rivaroxaban—Vomiting—Tamoxifen—pancreatic cancer	0.000364	0.00125	CcSEcCtD
Rivaroxaban—Hypotension—Fluorouracil—pancreatic cancer	0.000362	0.00124	CcSEcCtD
Rivaroxaban—Hypersensitivity—Sunitinib—pancreatic cancer	0.000361	0.00124	CcSEcCtD
Rivaroxaban—Rash—Tamoxifen—pancreatic cancer	0.000361	0.00124	CcSEcCtD
Rivaroxaban—Dermatitis—Tamoxifen—pancreatic cancer	0.000361	0.00124	CcSEcCtD
Rivaroxaban—Vomiting—Erlotinib—pancreatic cancer	0.00036	0.00124	CcSEcCtD
Rivaroxaban—Dyspnoea—Irinotecan—pancreatic cancer	0.00036	0.00124	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000359	0.00123	CcSEcCtD
Rivaroxaban—Headache—Tamoxifen—pancreatic cancer	0.000359	0.00123	CcSEcCtD
Rivaroxaban—Rash—Erlotinib—pancreatic cancer	0.000357	0.00123	CcSEcCtD
Rivaroxaban—Dermatitis—Erlotinib—pancreatic cancer	0.000357	0.00123	CcSEcCtD
Rivaroxaban—Angiopathy—Docetaxel—pancreatic cancer	0.000357	0.00122	CcSEcCtD
Rivaroxaban—Dyspepsia—Irinotecan—pancreatic cancer	0.000356	0.00122	CcSEcCtD
Rivaroxaban—Immune system disorder—Docetaxel—pancreatic cancer	0.000355	0.00122	CcSEcCtD
Rivaroxaban—Headache—Erlotinib—pancreatic cancer	0.000355	0.00122	CcSEcCtD
Rivaroxaban—Pain in extremity—Doxorubicin—pancreatic cancer	0.000355	0.00122	CcSEcCtD
Rivaroxaban—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000355	0.00122	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000355	0.00122	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000354	0.00122	CcSEcCtD
Rivaroxaban—Asthenia—Sunitinib—pancreatic cancer	0.000352	0.00121	CcSEcCtD
Rivaroxaban—Dyspnoea—Gemcitabine—pancreatic cancer	0.000351	0.0012	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00035	0.0012	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000349	0.0012	CcSEcCtD
Rivaroxaban—Fatigue—Irinotecan—pancreatic cancer	0.000348	0.0012	CcSEcCtD
Rivaroxaban—Pruritus—Sunitinib—pancreatic cancer	0.000347	0.00119	CcSEcCtD
Rivaroxaban—Pain—Irinotecan—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Rivaroxaban—Constipation—Irinotecan—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Rivaroxaban—Dyspnoea—Fluorouracil—pancreatic cancer	0.000345	0.00118	CcSEcCtD
Rivaroxaban—Dyspepsia—Fluorouracil—pancreatic cancer	0.000341	0.00117	CcSEcCtD
Rivaroxaban—Nausea—Tamoxifen—pancreatic cancer	0.00034	0.00117	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00034	0.00117	CcSEcCtD
Rivaroxaban—Fatigue—Gemcitabine—pancreatic cancer	0.000339	0.00117	CcSEcCtD
Rivaroxaban—Pain—Gemcitabine—pancreatic cancer	0.000337	0.00116	CcSEcCtD
Rivaroxaban—Constipation—Gemcitabine—pancreatic cancer	0.000337	0.00116	CcSEcCtD
Rivaroxaban—Nausea—Erlotinib—pancreatic cancer	0.000337	0.00116	CcSEcCtD
Rivaroxaban—Diarrhoea—Sunitinib—pancreatic cancer	0.000336	0.00115	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000334	0.00115	CcSEcCtD
Rivaroxaban—Feeling abnormal—Irinotecan—pancreatic cancer	0.000333	0.00114	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000332	0.00114	CcSEcCtD
Rivaroxaban—Back pain—Docetaxel—pancreatic cancer	0.000331	0.00114	CcSEcCtD
Rivaroxaban—Pain—Fluorouracil—pancreatic cancer	0.000331	0.00114	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00033	0.00113	CcSEcCtD
Rivaroxaban—Muscle spasms—Docetaxel—pancreatic cancer	0.000329	0.00113	CcSEcCtD
Rivaroxaban—Dizziness—Sunitinib—pancreatic cancer	0.000324	0.00111	CcSEcCtD
Rivaroxaban—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000324	0.00111	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000324	0.00111	CcSEcCtD
Rivaroxaban—Angina pectoris—Epirubicin—pancreatic cancer	0.000323	0.00111	CcSEcCtD
Rivaroxaban—Abdominal pain—Irinotecan—pancreatic cancer	0.000319	0.0011	CcSEcCtD
Rivaroxaban—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000319	0.0011	CcSEcCtD
Rivaroxaban—Anaemia—Docetaxel—pancreatic cancer	0.000316	0.00109	CcSEcCtD
Rivaroxaban—Vomiting—Sunitinib—pancreatic cancer	0.000312	0.00107	CcSEcCtD
Rivaroxaban—Rash—Sunitinib—pancreatic cancer	0.000309	0.00106	CcSEcCtD
Rivaroxaban—Dermatitis—Sunitinib—pancreatic cancer	0.000309	0.00106	CcSEcCtD
Rivaroxaban—Urticaria—Fluorouracil—pancreatic cancer	0.000307	0.00106	CcSEcCtD
Rivaroxaban—Headache—Sunitinib—pancreatic cancer	0.000307	0.00106	CcSEcCtD
Rivaroxaban—Syncope—Docetaxel—pancreatic cancer	0.000307	0.00105	CcSEcCtD
Rivaroxaban—Loss of consciousness—Docetaxel—pancreatic cancer	0.000301	0.00103	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—pancreatic cancer	0.000299	0.00103	CcSEcCtD
Rivaroxaban—Hypersensitivity—Irinotecan—pancreatic cancer	0.000298	0.00102	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—pancreatic cancer	0.000295	0.00101	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—pancreatic cancer	0.000295	0.00101	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000293	0.00101	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—pancreatic cancer	0.000291	0.001	CcSEcCtD
Rivaroxaban—Nausea—Sunitinib—pancreatic cancer	0.000291	0.001	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—pancreatic cancer	0.00029	0.000997	CcSEcCtD
Rivaroxaban—Asthenia—Irinotecan—pancreatic cancer	0.00029	0.000995	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000289	0.000994	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—pancreatic cancer	0.000288	0.000989	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—pancreatic cancer	0.000287	0.000986	CcSEcCtD
Rivaroxaban—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000285	0.000979	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—pancreatic cancer	0.000285	0.000978	CcSEcCtD
Rivaroxaban—Asthenia—Gemcitabine—pancreatic cancer	0.000282	0.00097	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—pancreatic cancer	0.000282	0.000967	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000279	0.000959	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000279	0.000959	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—pancreatic cancer	0.000279	0.000959	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—pancreatic cancer	0.000279	0.000957	CcSEcCtD
Rivaroxaban—Pruritus—Gemcitabine—pancreatic cancer	0.000279	0.000956	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—pancreatic cancer	0.000278	0.000953	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—pancreatic cancer	0.000277	0.000952	CcSEcCtD
Rivaroxaban—Diarrhoea—Irinotecan—pancreatic cancer	0.000277	0.000949	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—pancreatic cancer	0.000276	0.000947	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—pancreatic cancer	0.000275	0.000944	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—pancreatic cancer	0.000274	0.000941	CcSEcCtD
Rivaroxaban—Pruritus—Fluorouracil—pancreatic cancer	0.000274	0.00094	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—pancreatic cancer	0.000273	0.000939	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—pancreatic cancer	0.000273	0.000939	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—pancreatic cancer	0.000273	0.000936	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—pancreatic cancer	0.000271	0.000932	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000271	0.00093	CcSEcCtD
Rivaroxaban—Diarrhoea—Gemcitabine—pancreatic cancer	0.000269	0.000925	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—pancreatic cancer	0.000269	0.000923	CcSEcCtD
Rivaroxaban—Dizziness—Irinotecan—pancreatic cancer	0.000267	0.000917	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—pancreatic cancer	0.000267	0.000915	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—pancreatic cancer	0.000266	0.000915	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000266	0.000912	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—pancreatic cancer	0.000265	0.000911	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—pancreatic cancer	0.000265	0.000911	CcSEcCtD
Rivaroxaban—Diarrhoea—Fluorouracil—pancreatic cancer	0.000265	0.000909	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000262	0.000899	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—pancreatic cancer	0.000261	0.000896	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—pancreatic cancer	0.000261	0.000895	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000261	0.000895	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—pancreatic cancer	0.00026	0.000893	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000259	0.000888	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—pancreatic cancer	0.000258	0.000885	CcSEcCtD
Rivaroxaban—Vomiting—Irinotecan—pancreatic cancer	0.000257	0.000882	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—pancreatic cancer	0.000256	0.00088	CcSEcCtD
Rivaroxaban—Dizziness—Fluorouracil—pancreatic cancer	0.000256	0.000879	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000255	0.000876	CcSEcCtD
Rivaroxaban—Rash—Irinotecan—pancreatic cancer	0.000255	0.000875	CcSEcCtD
Rivaroxaban—Dermatitis—Irinotecan—pancreatic cancer	0.000255	0.000874	CcSEcCtD
Rivaroxaban—Headache—Irinotecan—pancreatic cancer	0.000253	0.000869	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—pancreatic cancer	0.000251	0.000861	CcSEcCtD
Rivaroxaban—Vomiting—Gemcitabine—pancreatic cancer	0.00025	0.000859	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—pancreatic cancer	0.000249	0.000855	CcSEcCtD
Rivaroxaban—Rash—Gemcitabine—pancreatic cancer	0.000248	0.000852	CcSEcCtD
Rivaroxaban—Dermatitis—Gemcitabine—pancreatic cancer	0.000248	0.000851	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—pancreatic cancer	0.000248	0.000851	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—pancreatic cancer	0.000247	0.000847	CcSEcCtD
Rivaroxaban—Headache—Gemcitabine—pancreatic cancer	0.000247	0.000847	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—pancreatic cancer	0.000246	0.000845	CcSEcCtD
Rivaroxaban—Vomiting—Fluorouracil—pancreatic cancer	0.000246	0.000845	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—pancreatic cancer	0.000246	0.000844	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—pancreatic cancer	0.000245	0.000843	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—pancreatic cancer	0.000245	0.000843	CcSEcCtD
Rivaroxaban—Rash—Fluorouracil—pancreatic cancer	0.000244	0.000838	CcSEcCtD
Rivaroxaban—Dermatitis—Fluorouracil—pancreatic cancer	0.000244	0.000837	CcSEcCtD
Rivaroxaban—Headache—Fluorouracil—pancreatic cancer	0.000242	0.000832	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000242	0.000832	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000241	0.000828	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000241	0.000828	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—pancreatic cancer	0.000241	0.000827	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—pancreatic cancer	0.000241	0.000826	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—pancreatic cancer	0.000241	0.000826	CcSEcCtD
Rivaroxaban—Nausea—Irinotecan—pancreatic cancer	0.00024	0.000824	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—pancreatic cancer	0.00024	0.000822	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000239	0.000821	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—pancreatic cancer	0.000239	0.00082	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—pancreatic cancer	0.000239	0.00082	CcSEcCtD
Rivaroxaban—Nausea—Gemcitabine—pancreatic cancer	0.000234	0.000803	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000232	0.000797	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—pancreatic cancer	0.00023	0.00079	CcSEcCtD
Rivaroxaban—Nausea—Fluorouracil—pancreatic cancer	0.00023	0.000789	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—pancreatic cancer	0.000229	0.000787	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000228	0.000784	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000228	0.000782	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—pancreatic cancer	0.000223	0.000767	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—pancreatic cancer	0.000223	0.000764	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—pancreatic cancer	0.000222	0.000762	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—pancreatic cancer	0.000222	0.000761	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000221	0.000759	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—pancreatic cancer	0.000221	0.000758	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000214	0.000735	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—pancreatic cancer	0.000213	0.000733	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—pancreatic cancer	0.000208	0.000715	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—pancreatic cancer	0.000207	0.000711	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—pancreatic cancer	0.000207	0.000709	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—pancreatic cancer	0.000206	0.000707	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—pancreatic cancer	0.000205	0.000705	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—pancreatic cancer	0.000203	0.000697	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—pancreatic cancer	0.0002	0.000688	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000198	0.00068	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—pancreatic cancer	0.000198	0.000679	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—pancreatic cancer	0.000197	0.000678	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—pancreatic cancer	0.000197	0.000675	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000195	0.00067	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—pancreatic cancer	0.000194	0.000667	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—pancreatic cancer	0.000193	0.000661	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—pancreatic cancer	0.000192	0.00066	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—pancreatic cancer	0.000192	0.000658	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—pancreatic cancer	0.000191	0.000656	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000188	0.000647	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—pancreatic cancer	0.000188	0.000647	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000188	0.000645	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—pancreatic cancer	0.000187	0.000643	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—pancreatic cancer	0.000185	0.000636	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—pancreatic cancer	0.000185	0.000634	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—pancreatic cancer	0.000185	0.000634	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—pancreatic cancer	0.000184	0.000631	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—pancreatic cancer	0.000183	0.000628	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—pancreatic cancer	0.000182	0.000624	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000181	0.00062	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—pancreatic cancer	0.00018	0.000617	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—pancreatic cancer	0.000178	0.000611	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—pancreatic cancer	0.000178	0.00061	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—pancreatic cancer	0.000176	0.000605	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—pancreatic cancer	0.000176	0.000604	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—pancreatic cancer	0.000176	0.000604	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—pancreatic cancer	0.000175	0.000601	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000174	0.000599	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—pancreatic cancer	0.000174	0.000599	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—pancreatic cancer	0.000173	0.000595	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—pancreatic cancer	0.000172	0.000589	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000171	0.000587	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—pancreatic cancer	0.00017	0.000584	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—pancreatic cancer	0.000169	0.000581	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—pancreatic cancer	0.000168	0.000577	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—pancreatic cancer	0.000166	0.00057	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—pancreatic cancer	0.000166	0.000569	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—pancreatic cancer	0.000163	0.000559	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000163	0.000558	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—pancreatic cancer	0.000162	0.000558	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—pancreatic cancer	0.000161	0.000553	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—pancreatic cancer	0.000161	0.000553	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—pancreatic cancer	0.000155	0.000534	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—pancreatic cancer	0.000155	0.000533	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000154	0.000529	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—pancreatic cancer	0.000153	0.000527	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000151	0.000517	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—pancreatic cancer	0.00015	0.000516	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—pancreatic cancer	0.00015	0.000514	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—pancreatic cancer	0.000149	0.000512	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—pancreatic cancer	0.000149	0.000512	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—pancreatic cancer	0.000149	0.000511	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000144	0.000493	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000143	0.000489	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—pancreatic cancer	0.000139	0.000477	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—pancreatic cancer	0.000139	0.000476	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—pancreatic cancer	0.000138	0.000473	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—pancreatic cancer	0.000135	0.000464	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—pancreatic cancer	0.000133	0.000458	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—pancreatic cancer	0.000129	0.000443	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000128	0.000441	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—pancreatic cancer	0.000125	0.000429	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—pancreatic cancer	0.000125	0.000428	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—pancreatic cancer	0.000123	0.000423	CcSEcCtD
Rivaroxaban—Vomiting—Epirubicin—pancreatic cancer	0.00012	0.000411	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—pancreatic cancer	0.000119	0.00041	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—pancreatic cancer	0.000119	0.000408	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—pancreatic cancer	0.000119	0.000408	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—pancreatic cancer	0.000118	0.000405	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—pancreatic cancer	0.000115	0.000396	CcSEcCtD
Rivaroxaban—Nausea—Epirubicin—pancreatic cancer	0.000112	0.000384	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—pancreatic cancer	0.000111	0.000381	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—pancreatic cancer	0.00011	0.000377	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—pancreatic cancer	0.00011	0.000377	CcSEcCtD
Rivaroxaban—Headache—Doxorubicin—pancreatic cancer	0.000109	0.000375	CcSEcCtD
Rivaroxaban—Nausea—Doxorubicin—pancreatic cancer	0.000104	0.000356	CcSEcCtD
